Downregulation of Ras C-terminal processing by JNK inhibition

Biochemical and Biophysical Research Communications

Volumn 371, Issue 2, 2008, Pages 273-277

  Mouri, Wataru ^a,b   Tachibana, Ken ^a   Tomiyama, Arata ^a   Sunayama, Jun ^a   Sato, Atsushi ^a   Sakurada, Kaori ^a   Kayama, Takamasa ^a   Kitanaka, Chifumi ^a,b  

^a YAMAGATA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

C terminal processing; JNK; Post translational modification; Ras; Regulation

Indexed keywords

RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; AUTOCRINE EFFECT; CARBOXY TERMINAL SEQUENCE; CELL DENSITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; ULTRAVIOLET IRRADIATION;

CELL COUNT; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MAP KINASE KINASE 4; ONCOGENE PROTEIN P21(RAS); PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 43049164282     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.057     Document Type: Article

References (17)

1. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003) 11-22
2. Hancock J.F. Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell Biol. 4 (2003) 373-384
3. Downward J. Regulatory mechanisms for ras proteins. Bioessays 14 (1992) 177-184
4. Chi S., Kitanaka C., Noguchi K., Mochizuki T., Nagashima Y., Shirouzu M., Fujita H., Yoshida M., Chen W., Asai A., Himeno M., Yokoyama S., and Kuchino Y. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18 (1999) 2281-2290
5. Kitanaka C., and Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6 (1999) 508-515
6. Kitanaka C., Kato K., Ijiri R., Sakurada K., Tomiyama A., Noguchi K., Nagashima Y., Nakagawara A., Momoi T., Toyoda Y., Kigasawa H., Nishi T., Shirouzu M., Yokoyama S., Tanaka Y., and Kuchino Y. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J. Natl. Cancer Inst. 94 (2002) 358-368
7. Hancock J.F., Magee A.I., Childs J.E., and Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57 (1989) 1167-1177
8. Gutierrez L., Magee A.I., Marshall C.J., and Hancock J.F. Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis. EMBO J. 8 (1989) 1093-1098
9. Shih T.Y., Weeks M.O., Gruss P., Dhar R., Oroszlan S., and Scolnick E.M. Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus. J. Virol. 42 (1982) 253-261
10. Carboni S., Hiver A., Szyndralewiez C., Gaillard P., Gotteland J.P., and Vitte P.A. AS601245 (1,3-benzothiazol-2-yl(2-[[2-(3-pyridinyl)ethyl]amino]-4 pyrimidinyl)acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J. Pharmacol. Exp. Ther. 310 (2004) 25-32
11. Goalstone M., Carel K., Leitner J.W., and Draznin B. Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway. Endocrinology 138 (1997) 5119-5124
12. Montagnani M., Golovchenko I., Kim I., Koh G.Y., Goalstone M.L., Mundhekar A.N., Johansen M., Kucik D.F., Quon M.J., and Draznin B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J. Biol. Chem. 277 (2002) 1794-1799
13. Kato K., Cox A.D., Hisaka M.M., Graham S.M., Buss J.E., and Der C.J. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc. Natl. Acad. Sci. USA 89 (1992) 6403-6407
14. Philips M.R., and Cox A.D. Geranylgeranyltransferase I as a target for anti-cancer drugs. J. Clin. Invest. 117 (2007) 1223-1225
15. Heasley L.E., and Han S.Y. JNK regulation of oncogenesis. Mol. Cells 21 (2006) 167-173
16. Ennis B.W., Fultz K.E., Smith K.A., Westwick J.K., Zhu D., Boluro-Ajayi M., Bilter G.K., and Stein B. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase. J. Pharmacol. Exp. Ther. 313 (2005) 325-332
17. Mo L., Zheng X., Huang H.Y., Shapiro E., Lepor H., Cordon-Cardo C., Sun T.T., and Wu X.R. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. J. Clin. Invest. 117 (2007) 314-325